December 10, 2020 4:42 PM | With information from EFE
15 minutes. An advisory committee of the US Food and Drug Administration (FDA, in English) began Thursday to evaluate the risks and benefits of Pfizer’s vaccine against COVID-19, which the government intends to begin distributing 48 hours later. to be approved.
“Today we will consider whether millions of Americans should have access to a vaccine that is under investigation and that has been developed, tested and investigated in record time,” said the deputy director of the Vaccines Division and the Office of FDA investigation, Doran Fink.
The meeting of the so-called FDA Vaccine and Related Biological Products Advisory Committee began at 9:00 local time (14:00 GMT). This will last until 18:00 local time (23:00 GMT).
Sometime in the afternoon, that organism vote to decide whether or not to recommend the FDA to urgently authorize the vaccine from Pfizer.
That committee recommendation will not be the final decision; It will be the FDA who will decide whether or not to give the vaccine the green light, although it usually follows the advice of these commissions.
Meeting with the FDA
This Thursday’s committee is made up of 30 experts, from specialists in infectious diseases to prestigious university professors. Some of them will act as consumer representatives and others as delegates from the pharmaceutical industry.
The meeting is held online due to the pandemic. In fact, due to the large number of experts participating, the first half hour was dedicated only to presentations.
The FDA decided to broadcast the meeting on YouTube in an attempt to make the process as transparent as possible and increase the confidence of Americans in the vaccine, since a large part of the population does not trust the process.
Specifically, only 60% of Americans are convinced that they will get the vaccine. The rest still harbor some degree of skepticism, according to data from the Pew Research Center.
If the FDA decides to approve the Pfizer vaccine, The United States will become the fifth country in the world to approve this remedy after the United Kingdom, Bahrain, Canada and Saudi Arabia.
Rapid access to a vaccine gained even greater importance in the United States after 3,124 deaths from COVID-19 were recorded on Wednesday, a number greater than the number of Americans who died in the attacks of September 11, 2001.